# Thyroxine Supplementation in Small for Gestational Age (SGA) Infants With Birth Weight <1500g and TSH 6-20 mIU/ml

> **NCT07625722** · NA · NOT_YET_RECRUITING · sponsor: **Shandong Provincial Hospital** · enrollment: 106 (estimated)

## Conditions studied

- Thyroid Function
- Preterm
- SGA and Growth
- Neurodevelopment Outcome

## Interventions

- **DRUG:** Levothyroxine Sodium (LT4) Tablets

## Key facts

- **NCT ID:** NCT07625722
- **Lead sponsor:** Shandong Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-20
- **Primary completion:** 2027-06-20
- **Final completion:** 2029-06-20
- **Target enrollment:** 106 (ESTIMATED)
- **Last updated:** 2026-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07625722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07625722, "Thyroxine Supplementation in Small for Gestational Age (SGA) Infants With Birth Weight <1500g and TSH 6-20 mIU/ml". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07625722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*